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Abstract 
Background: Gastric mucosal lesion (GML) is the initiating pathological process in many refractory gastric diseases. 
And moxibustion is an increasingly popular alternative therapy that prevents and treats diseases. However, there are 
few published reports about developing pathology of GML and therapeutic mechanism of moxibustion treatment on 
GML. In this study, we investigated pathology of GML and therapeutic mechanism of moxibustion treatment on GML.
Methods: The male Sprague‑Dawley (SD) rats were induced by intragastric administration of 75% ethanol after 
fasting for 24 h and treated by moxibustion at Zusanli (ST36) and Liangmen (ST21) for 1 day, 4 days or 7 days. Then 
we applied 1H NMR‑based metabolomics to dynamic analysis of metabolic profiles in biological samples (stomach, 
cerebral cortex and medulla). And the conventional histopathological examinations as well as metabolic pathways 
assays were also performed.
Results: Moxibustion intervention showed a beneficial effect on GML by modulating comprehensive metabolic 
alterations caused by GML, including energy metabolism, membrane metabolism, cellular active and neurotransmit‑
ters function.
Conclusions: Moxibustion can effectively treat gastric mucosal damage and effectively regulate the concentration of 
some related differential metabolites to maintain the stability of the metabolic pathway.
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Background
Gastric mucosal lesions (GML), characterized by gastric 
mucosal inflammation, erosion and bleeding, is com-
monly caused by emotional stress, physical and chemical 
factors, microorganisms and other factors [1]. It is widely 
known that GML is the initial pathological of refrac-
tory intractable gastric diseases such as Chronic Gas-
tric Ulcers (CGU), chronic atrophic gastritis (CAG) and 
gastric cancer [2–4]. In modern medicine, GML is mainly 
treated by proton pump inhibitor (PPI) combined with 
antibiotics or histamine 2-antagonist, or surgery includ-
ing helicobacter pylori eradication [5]. Although these 
treatments make a considerable contribution to control 
of GML, they are not very satisfying because of their lim-
ited application in clinical, higher expensive cost, long-
term treatment as well as some adverse effects. Recently, 
the traditional Chinese medicine (TCM) has accepted 
by more and more people as a complementary alterna-
tive and increasingly accepted by the general people 
because of their significant efficacy, lower costs and few 
side-effects.
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Moxibustion, as the intrinsic part of TCM, exerts 
therapeutic effects mainly by the heat stimulating acu-
points from moxa burning [6, 7]. Currently, several 
studies have showed a therapeutic effective of moxi-
bustion on GML [8–10]. And our previous studies 
have proved that moxibustion on acupoints of Stom-
ach Meridian can effectively regulate the expression of 
genes or proteins associated with the proliferation and 
apoptosis signaling in gastric mucosa rats with GML 
[11, 12]. But the limited targets and single time point 
lead to a part of information for us to understand-
ing pathology of GML and mechanism of moxibus-
tion treatment since the complexity and unpredictable 
ways in organisms respond to stimuli due to diseases 
or interventions. So, the time-related metabolic pro-
files in organisms are urgently needed to observe for a 
more complete picture.
Metabolomics is an emerging system biological 
approach after genomics and proteomics. NMR-based 
metabolomics can be used to identify metabolic reac-
tions and potential biomarkers, it can analyse hun-
dreds or even thousands of samples in a relatively 
short period of time with the help of an auto sample 
[13]. Meanwhile, metabolomics is a powerful approach 
for studying pathophysiological processes, and metab-
olomic analysis of human samples may shed light on 
the mechanisms of gastric mucosal and help iden-
tify potential therapeutic targets [14]. It can analysis 
changes of metabolic profiles caused by disease and 
other stimuli from a holistic view, which coincides 
exactly with the TCM theory [15]. Nuclear magnetic 
resonance (NMR) is one of the most commonly used 
platform in metabolomics studies for its advantages 
including low per-sample cost, non-invasive and non-
selective analysis [16]. Many studies have revealed that 
the metabolism of amino acids, sugars and lipids in the 
body is disordered after gastric mucosal injury. Meta-
bolic abnormalities are one of the key pathological 
aspects of gastric mucosal injury [17, 18]. Therefore, 
the overall regulation characteristics of acupuncture 
and moxibustion are in line with the technical advan-
tages of metabolomics. The use of metabolomics to 
study acupuncture theory and its mechanism of action 
may become the common language for Chinese tra-
ditional medicine to become international. Currently, 
metabolomics was increasingly applied for therapeu-
tic mechanisms of TCM including moxibustion [19, 
20]. In this study, to a better understanding for thera-
peutic mechanism of moxibustion on GML rats, the 
time-related metabolic profiles of samples (stomach, 
cerebral cortex and medulla) in GML rats were ana-
lyzed by 1H NMR-based metabolomics.
Methods
Reagents and materials
Deuterium oxide  (D2O) and sodium 3-trimethylsilyl-(2, 
2, 3, 3-d4)-1-propionate (TSP) were purchased from 
Sigma-Aldrich (St, Louis, MI, USA). Trichloroacetalde-
hyde hydrate was purchased from Sinopharm Chemi-
cal Reagent Co., Ltd (Shanghai, China). Hematoxylin 
solution and eosin solution for histological stain were 
purchased from Beijing Leagene Biotechnology Co., 
Ltd (Beijing, China). Moxa cones were obtained from 
Nanyang Xian Cao Pharmaceuticals Co., Ltd (Nanyang, 
China). All other used chemicals were of analytical 
grade.
Animals
72 healthy male Sprague-Dawley (SD) rats (180–220 g) 
were used in this study. Animals were purchased from 
the experimental animal center of Wu (Permit Number: 
SCXK160803004). Animal care and experimental pro-
cedures used in this study were approved by the Animal 
Care and Use Committee of Xiamen University. The 
study was performed with the guidelines of National 
Institutes of Health for the Care and Use of Labora-
tory Animals. And the animals were euthanized after 
intervention.
Animal preparation and grouping
All animals were maintained in a controlled condition 
(22 ± 1 °C, relative humidity of 65 ± 5%, and 12-h light/
dark cycle) with ad  libitum to feed and water. After 
1-week adaptation, all rats were randomly separated 
into four groups: (a) control group, (b) gastric mucosal 
lesions (GML) model group, (c) GML rats with moxi-
bustion treatment on the stomach meridian of Foot-
Yangming (SMFY) acupoints (MA group), and (d) GML 
rats with moxibustion on non-acupoints (MNA). All 
rats except for controls were randomly divided into 
three subgroups (n = 6, per subgroup). In the first sub-
group, rats were executed at 1 day after treatment. As 
mentioned above, the rats from second and third sub-
group was sacrificed at 4 days and 7 days, respectively. 
All rats except for controls were established GML mod-
eling with alcohol given by gavage with 75% ethanol 
solution at 4 mL/kg after deprived of food for 24 h [21].
Moxibustion treatment
After GML modeling, Liangmen (ST 21) and Zusanli 
(ST 36) acupoints of rats in first, second and third sub-
groups were selected for MA stimulation for 1  day, 
4  days and 7  days. And these two acupoints were 
located according to the Veterinary Acupuncture of 
China and Government Channel and Points Standard 
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GB12346-90 of China. Corresponding non-acupoints 
were located 5  mm away from acupoints mentioned 
above. And these non-acupoints were neither related 
to stomach meridian nor overlap with other known 
acupoints.
For moxibustion treatment, moxa cones (height: 5 mm, 
diameter: 5 mm, “Han Medicine”, Nanyang, China) were 
ignited and fixed at 2  cm above the selected spots (a 
30-min session per day) in MA group as well as the non-
acupoints in MNA group. Rats in GML model group were 
performed with no treatment but similar administration.
Biological sample collections
The animals from three subgroups were respectively sac-
rificed anesthetized with isoflurane in day 1, day 4 and 
day 7. Then the cerebral cortex, medulla and stomach tis-
sue samples were excised and snap-frozen in liquid nitro-
gen immediately for tissue extraction. All of samples were 
stored at − 80 °C prior to analysis.
Histopathological examination
After dehydration of gastric tissues samples fixed in 
4% paraformaldehyde, routine paraffin imbedding was 
applied. Then the 5-μm thick sections were sliced. Depar-
affinage and hydration of the sections were achieve by 
soaking in xylenes I, II and gradient alcohol solution 
(absolute alcohol, 95% alcohol, 85% alcohol and 75% 
alcohol). Subsequently, samples were washed in water 
and stained with hematoxylin and eosin. Finally, a his-
topathological examination was conducted under light 
microscopy.
Evaluation of gastric ulcer index
The rats were sacrificed anesthetized by inhaled isoflu-
rane after treatment. The stomach was cut open along 
the greater curvature and washed with 0.9% Nacl solu-
tion. The area of gastric ulcer was measured with a ver-
nier caliper and the index of gastric ulcer was counted. 
The severity of gastric lesions are scored as follows: pete-
chial spots = 1, erosions < 1  mm = 2, erosions between 
1 and 2 mm = 3, erosions between 2 and 4 mm = 4, and 
erosions greater than 4  mm = 5, and when the width of 
ulceration was < 1  mm the score was multiplied by 2. 
Then, the final total lesion score was obtained from the 
summery of the partial scores.
Biological samples preparation and 1H NMR experiments
According to our preliminary study [22], each of pre-
weighed stomach, cerebral cortex, medulla samples 
(200  mg) were homogenated in 600  mL of  CH3OH 
and 300  mL of  H2O and then vortexed for 1  min. 
After partitioning on ice for 10 min, the samples were 
centrifuged for 10  min (10,000  rpm, 4  °C). Next, the 
upper supernatant were piped into tubes for lyophi-
lization and then mixed with 600  μL  D2O comprising 
sodium 3-trimethylsilyl-(2, 2, 3, 3-d4)-1-propionate 
(TSP). Finally, the mixture was transferred into 5  mm 
NMR tube to perform NMR analysis.
1H NMR spectra of these samples were captured 
using a Bruker 600 MHz spectrometer at 298 K as well. 
Standard 1D 1H spectra were obtained with a ‘NOESY’ 
(RD-901-t1-90°-tm-90°-acquire) pulse sequence. For 
each sample, 64 FIDs were collected into 64  K data 
points over a spectral width of 12,000 Hz with a relaxa-
tion delay of 6.5 μs. The metabolites in all samples of 1H 
NMR spectra were assigned according to reference in 
published literature [22–24], in-house developed NMR 
database and HMDB database.
Data preprocessing and multivariate statistical analysis
MestReNova v9.0.1 software (Mestrelab Research, San-
tiago de Compostela, Spain) was utilized to phase and 
baseline correct the 1H NMR spectra from all samples. 
And the 1H NMR spectra were referenced to a single 
peak from TSP at 0.0  ppm and peak-aligned to deal 
with peak-shift problem. To obviate the influence of 
water, the chemical shift range of δ 4.70–5.2 ppm were 
removed. Then the spectra were segmented at δ 0.01 
intervals across the region of 0.5–9.0 ppm. The integral 
values were normalized to a sum of all integrals in each 
spectrum to compensate for concentration differences 
between the samples. Thus, the forming date matrices 
were conducted further for multivariate analysis.
The 1H NMR spectral data was processed with 
SIMCA-P14.1 (Umetrics, Sweden) to elucidate patterns 
of metabolic profiles. Prior to multivariate analysis, the 
Pareto-scaling was conducted to decrease the effect 
of noise and artefacts in the models. First, a principal 
component analysis (PCA) was carried out for a natu-
ral separation among the all groups via visual inspec-
tion of the score plots in this study. Next, the projection 
to latent structures discriminant analysis (PLS-DA) 
and supervised orthogonal projection to latent struc-
tures discriminant analysis (OPLS-DA) were conducted 
to distinguish different groups. In addition, the qual-
ity of OPLS-DA model was assessed by parameter R2 
for model fitness and parameter Q2 for model predic-
tive ability. Subsequently, the corresponding S-plot of 
OPLS-DA model was carried out to discover the poten-
tial variables for differentiation. The potential biomark-
ers were filtered according to the variable importance 
in the project (VIP) of the established OPLS-DA model 
(VIP > 1.00) and an independent-sample t-test (p < 0.05) 
using (SPSS21.0).
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Results
Histological morphology examinations
Histological morphology examinations of the gastric 
mucosal tissues from rats in 12 groups were respec-
tively conducted (Fig.  1 and Additional file  1: Figure 
S1). For controls in three time points, it was showed 
that the structure of mucous epithelium were preserved 
integrated with well-arranged cells and there were no 
inflammatory cellular infiltration in the submucosa and 
muscularis. At 1  day, rats except for the controls pre-
sented a seriously damaged structure of mucous mem-
brane with a large number of cell necrosis and abscission, 
significant inflammatory cellular infiltration in submu-
cosa and muscularis, where cells were arrayed in dis-
ordered state. The result was in accord with the gastric 
lesions indexes of rats in GML group, MA group and 
MNA group (Table 1), which were all higher significantly 
than the control at day 1 (all p < 0.01). Based on these 
observations, the rat modeling of GML was a successful 
replication. For the GML rats at 4  days and 7  days, the 
histological morphology examinations showed a partly 
improved in structure of mucosa and inflammatory cel-
lular infiltration, indicating a self-restoring occurring 
during the development of GML. On the other hand, the 
gastric mucosa of GML rats with moxibustion treatment 
were decreased in lesions index at 4 days and improved 
in different degrees with the structure of gastric mucosa 
and inflammatory cellular infiltration at 4  days and 
7  days, where ameliorated better than GML group at 
the same time point. These observations illustrate that 
moxibustion treatment a good effect on rats with GML 
Fig. 1 Histological morphology of gastric mucosa from 12 groups. a1, b1, c1 and d1, rats in control group, gastric mucosal lesions model group, 
moxibustion‑acupoint group and moxibustion‑nonacupoint group at 1 day, respectively; a2, b2, c2 and d2, rats in control group, gastric mucosal 
lesions model group, moxibustion‑acupoint group and moxibustion‑nonacupoint group at 4 days, respectively; a3, b3, c3 and d3, rats in control 
group, gastric mucosal lesions model group, moxibustion‑acupoint group and moxibustion‑nonacupoint group at 7 days, respectively; Scale bars 
represent 50 μm in each group
Table 1 Gastric lesions indexes of  rats in  the  four groups 
at day 1, 4 and 7 (mean ± S.D)
Data presented as mean ± standard error of the mean
* or **Denotes a statistical significance p < 0.05 or p < 0.01 when compared with 
the control group
▲  or ▲▲Denotes a statistical significance p < 0.05 or p < 0.01 when compared 
with the GML group
✦ Denotes a statistical significance p < 0.05 when compared with the MNA 
group
Group Day 1 (n = 6) Day 4 (n = 6) Day 7 (n = 6)
Control 0.17 ± 0.41 0.67 ± 0.82 0.67 ± 0.82
GML 22.17 ± 2.56** 10.33 ± 2.80** 1.83 ± 1.94
MA 19.17 ± 2.56** 3.67 ± 2.50*✦▲▲ 1.17 ± 1.1
MNA 20.17 ± 2.32** 6.83 ± 1.94**▲ 1.67 ± 1.62
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rats. Besides, compared with the same time point of rats 
in MA group and MNA group, there is more significant 
improvement in gastric lesions index and gastric mucosa 
of GML rats with moxibustion on acupoints treatment. 
It suggests that moxibustion treatment on acupoints had 
relatively better effect on rats with GML.
Gastric ulcer index detection
The gastric ulcer index was measured in 12 groups of 
rats (Table 1). Compare to the control, the gastric lesions 
indexes of GML group, MA group and MNA group were 
higher significantly at day 1 (all p < 0.01), indicating the 
GML modeling was replicated successfully. In addition, 
the gastric lesions index of rats in MA group was the low-
est among the GML group, MA group and MNA group 
at day 4, demonstrating that moxibustion acupoints has 
better beneficial effective on gastric lesion in GML rats.
1H NMR profiles of stomach and brain tissues from rats
To investigate the time-relative metabolic changes cor-
related with the therapeutic mechanism of moxibustion 
on GML, the metabolic profiles of stomach, cerebral 
cortex and medulla exacts were detected with 1H NMR-
based metabolomics at 1 day, 4 days and 7 days. The main 
metabolites from the spectra were identified according 
to our own developed NMR database, Human Metabo-
lome Database (HMDB: http://www.hmdb.ca/) and 
literature data. A list of quantified metabolites from dif-
ferent matrices is shown in Additional file 1: Table S1 and 
typical 1H NMR spectra of stomach, cerebral cortex and 
medulla extracts are demonstrated (Fig. 2).
Due to the complexity of the spectra, visual inspect-
ing of these 1H NMR spectra showed less obvious differ-
ence. Therefore, all datasets were subsequently analyzed 
using PLS-DA and tow-group of OPLS-DA to discover 
any potential variables related to GML and moxibustion 
treatment. For all tissue types, the OPLS-DA scores from 
the control group and GML group showed obvious sepa-
rations in three time points (Fig. 3), indicating a notice-
able metabolic profiles perturbation occurred in GML. 
On the other hand, MA group separated obviously from 
GML group (Fig.  4), suggesting that moxibustion treat-
ment had an obvious effect on GML.
In order to further filter the metabolites related to 
GML pathology and moxibustion treatment, we per-
formed the corresponding S-plot and t-test (Additional 
file 1: Figures S2, S3).
Fig. 2 Typical 1H NMR spectra of aqueous extracts from stomach, medulla and cerebral cortex tissues. 1, Low density lipoprotein; 2, very low density 
lipoprotein; 3, isoleucine; 4, leucine; 5, valine; 6, 2‑oxoisovalerate; 7, ethanol; 8, methylmalonate; 9, lactate; 10, threonine, 11, alanine; 12, lysine, 13, 
γ‑aminobutyrate; 14, acetate; 15, N‑acetyl aspartate; 16, glutamate; 17, glutamine; 18, methionine; 19, glutathione; 20, pyruvate; 21, oxaloacetate, 
22, succinate, 23, α‑ketoglutarate; 24, citrate, 25, sarcosine, 26, aspartate; 27, N,N‑dimethylglycine; 28, creatine; 29, creatinine, 30, phenylalanine; 31, 
ethanolamine; 32, choline; 33, phosphocholine; 34, glycerophosphocholine; 35, β‑glucose; 36, taurine; 37, myo‑inositol; 38, methanol; 39, α‑glucose; 
40, glycine; 41, glycerol; 42, glycogen; 43, guanidoacetate; 44, serine; 45, hippurate; 46, inosine; 47, adenosine; 48, NAD+; 49, allantoin; 50, uridine 
diphosphate glucose; 51, uracil; 52, cytidine; 53, uridine; 54, fumarate; 55, tyrosine; 56, histidine; 57, 3‑methylhistidine; 58, xanthine; 59, nicotinamide
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Compared with the controls, the levels of β-glucose, 
α-glucose, pyruvate, oxaloacetate, citrate, acetate, iso-
leucine, leucine, valine, aspartate, phenylalanine, tyrosine 
and glutamate in stomach tissues of GML rats under-
went significant changes as follows (Additional file  1: 
Table S2): (a) glutamine was decreased at 1 day; (b) pyru-
vate, oxaloacetate, glutamate were decreased at 1 day and 
4 days; (c) β-glucose and α-glucose was found to increase 
at 1 day while decrease at 4 days; (d) acetate, isoleucine, 
leucine, valine, lysine, tyrosine and phenylalanine was 
decrease at 1 day while increase at 4 days; (e) citrate and 
aspartate were increase at 7  days. And the metabolites 
mentioned above in rats with moxibustion treatment, 
compared with GML rats, were reversed as follows: (a) 
glutamine, β-glucose, acetate, isoleucine, leucine, valine, 
lysine, tyrosine and phenylalanine were reversed by both 
moxibustion on acupoints and non-acupoints for 1 day; 
(b) aspartate was up-regulation by both moxibustion 
acupoints and non-acupoints for 1  day; (c) α-glucose, 
pyruvate, oxaloacetate and glutamate were reversed by 
moxibustion on acupoints for 1 day while by moxibustion 
non-acupoints for 4  days; (d) citrate was increased by 
moxibustion on acupoints for 1 day while by moxibustion 
non-acupoints for 4 days.
On the other hand, for metabolites in cerebral cortex 
tissues of GML rats, the levels of creatine, succinate, 
α-ketoglutarate, fumarate, GPC, taurine, glutamate and 
glutamine were altered compared with the controls as 
follows (Additional file  1: Table  S3): (a) creatine was 
increased at 1 day; (b) succinate, α-ketoglutarate, fuma-
rate and taurine were decreased at 1  day; (c) GPC was 
increased at 1 day and decreased at 7 days; (d) glutamate 
and glutamine were decreased at 1  day and at 4  days 
while increased at 7  days. And compared with GML 
groups, the levels of (a) succinate, creatine, glycerophos-
phocholine, fumarate were reversed by moxibustion 
acupoints at 1  day and succinate showed an increasing 
trend at 7 days while creatine and glycerophosphocholine 
showed a descended trend at 4 days by both moxibustion 
acupoints and non-acupoints; (b) taurine was elevated by 
Fig. 3 OPLS‑DA scores plots from the GML rats and the control rats in stomach tissues at 1 day (a1, R2X = 0.695, R2Y = 0.987, Q2 (cum) = 0.68), 
4 days (a2, R2X = 0.944, R2Y = 0.999, Q2 (cum) = 0.877) and 7 days (a3, R2X = 0.687, R2Y = 0.981, Q2 (cum) = 0.4); in cerebral cortex tissues at 1 day 
(b1, R2X = 0.743, R2Y = 0.993, Q2 (cum) = 0.937), 4 days (b2, R2X = 0.77, R2Y = 0.983, Q2 (cum) = 0.801) and 7 days (b3, R2X = 0.852, R2Y = 0.999, Q2 
(cum) = 0.981); in medulla tissues at 1 day (c1, R2X = 0.821, R2Y = 0.981, Q2 (cum) = 0.82), 4 days (c2, R2X = 0.718, R2Y = 0.991, Q2 (cum) = 0.815) 
and 7 days (c3, R2X = 0.817, R2Y = 0.994, Q2 (cum) = 0.79)
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both moxibustion acupoints and non-acupoints for 1 day 
and keep increasing at 4 days by moxibustion acupoints; 
(c) glutamate and glutamine were elevated at 1  day and 
4 days by both moxibustion acupoints and non-acupoints 
and glutamate showed a declined trend to normal at 
7 days by moxibustion acupoints.
Additionally, we also found that, in medullary sam-
ples of rats, the levels of citrate, lactate, phenylalanine, 
glutathione, glycine, serine and methionine were sig-
nificantly changed by GML modeling (Additional file  1: 
Table  S4): (a) lactate was increased at 1  day; (b) citrate 
was decreased at 1  day; (c) glycine and phenylalanine 
were decreased at 1 day and 4 days; (d) methionine and 
serine were decreased at 1 day while increased at 4 days 
and 7  days; (e) glutathione was decreased at 1  day and 
increased at 7 days. And these metabolites were reversed 
in response to moxibustion treatments for 1 day. Threo-
nine, citrate and glutathione kept increasing significantly 
at 4  days by both moxibustion acupoints and non-acu-
points treatments. Specially, the levels of serine at 4 days 
and phenylalanine at 7 days kept a noticeable increasing 
by moxibustion acupoints.
Discussion
It is known that the functional dyspepsia is closely related 
to brain-gut peptide (BGP), which is effective in regulat-
ing various physiological functions in gastrointestinal 
tract by both enteric nervous system and central nerv-
ous system [25]. Interestingly, it has been reported that 
the gut-brain axis plays a potential role in gastric damage 
and protection [26]. And the cerebral cortex and medulla 
as the main tissue of the brain-intestinal axis, the effects 
Fig. 4 OPLS‑DA scores plots from the GML rats and the GML rats with moxibustion acupoints (MA) treatment in stomach tissues at 1 day (a1, 
R2X = 0.729, R2Y = 0.999, Q2 (cum) = 0.959), 4 days (a2, R2X = 0.937, R2Y = 0.999, Q2 (cum) = 0.971) and 7 days (a3, R2X = 0.674, R2Y = 0.997, 
Q2 (cum) = 0.842); in cerebral cortex tissues at 1 day (b1, R2X = 0.759, R2Y = 0.999, Q2 (cum) = 0.996), 4 days (b2, R2X = 0.817, R2Y = 0.999, Q2 
(cum) = 0.993) and 7 days (b3, R2X = 0.923, R2Y = 1, Q2 (cum) = 0.937); in medulla tissues at 1 day (c1, R2X = 0.739, R2Y = 0.974, Q2 (cum) = 0.791), 
4 days (c2, R2X = 0.78, R2Y = 0.998, Q2 (cum) = 0.956) and 7 days (c3, R2X = 0.673, R2Y = 0.987, Q2 (cum) = 0.746)
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of the brain-intestinal axis on the gastrointestinal tract 
can be reflected by the changes of the cerebral cortex and 
medulla in the whole experimental process. Meanwhile, 
in Traditional Chinese Medicine (TCM), the stomach 
meridian had an important connection with the stom-
ach. The stomach diseases can be treated by stimulating 
the acupoints which on the stomach meridian [11, 27]. 
So the stomach is mainly related to meridians and can 
visually reflect local changes. The development of gastric 
mucosa lesions is a complex process including the occur-
rence and healing [28]. For all sample types, the different 
levels of changes caused by GML modeling and reversed 
by moxibustion treatment may bring about characteristic 
metabolomics profiles of GML modeling and moxibus-
tion treatment, which will be discussed in further detail 
as following (Additional file 1: Figure S4).
Metabolic alterations in stomach tissues
Glucose is the primary source of energy involving in glyc-
olysis or gluconeogenesis. And pyruvate is a key interme-
diate in metabolism of carbohydrates, fats and proteins 
[29, 30]. Additionally, acetate is mainly utilized in the 
form of acetyl-CoA, an essential metabolite in three car-
boxylic acid (TCA) cycle. Besides, citrate and oxaloace-
tate are also important intermediates during TCA cycle. 
Previously, decreased citrate in stomach extracts was 
also recognized as potential biomarker for severe gastric 
ulcers [23]. In current study, alteration of glucose caused 
by GML at 1 day and 4 days indicates that GML modeling 
may bring an unbalance between the glycolysis and glu-
coneogenesis. In addition, lower levels of pyruvate, ace-
tate, citrate and oxaloacetate in stomach tissues of GML 
rats at 1  day while increased concentration of citrate at 
7 days suggest that GML modeling may cause an inhibi-
tion in TCA cycle for energy releasing and this inhibition 
disappears with the improvement of lesions. On the other 
hand, compared with moxibustion non-acupoints treat-
ment, the more levels of metabolites mentioned above 
can be revered after moxibustion acupoints treatment for 
1  day, suggesting that moxibustion acupoints treatment 
may play an important role in regulating energy metabo-
lism at early stage during development of GML (Fig. 5).
Leucine, isoleucine and valines, branched-chain amino 
acids (BCAAs), play a functional role in accelerating 
mitochondrial metabolism, which lead to promote cell 
metabolism and improve immune-related function and 
gastrointestinal health [31–35]. And lysine is a precursor 
of cadaverine, an essential factor in fatty acid metabo-
lism through transporting fat into the mitochondria for 
subsequent β-oxidation [36]. Phenylalanine is required 
for the synthesis of tyrosine, which readily passes the 
blood–brain barrier and is a precursor for the neuro-
transmitters dopamine, norepinephrine and epinephrine. 
Glutamate can interconvert into glutamine, which is vital 
energy source to promote mucosal and play important 
role in maintaining the structure and function of intesti-
nal mucosa [37]. Aspartate is another nonessential amino 
acid and plays beneficial roles in anti-oxidative capacity, 
immunity, gastrointestinal absorptive and mucosal bar-
rier function [38, 39]. Depletion in these amino acids in 
stomach tissues of GML rats at 1 day indicates that GML 
modeling may lead to disorders in immune-and neuro-
transmitters-related function as well as anti-oxidative 
capacity. And this depletion is reversed with the improve-
ment of lesions. On the other hand, most of these amino 
acids are reversed for 1  day and keep a increasing dur-
ing the development process of lesions, indicating that 
moxibustion have a beneficial treatment by regulating 
anti-oxidative capacity, immunity and the function of 
neurotransmitters (Fig. 5).
Metabolic alterations in brain
Citrate, α-ketoglutarate (α-KG), succinate and fumarate 
are important intermediates in TCA cycle. And lactate is 
final product from pyruvate in anaerobic cellular metab-
olism. Creatine functions as part of the cell’s energy shut-
tle that it can transfer ATP and provide energy through 
catalyzed to phosphocreatine and ADP [22]. Alteration 
of these metabolites in brain of GML rats suggests again 
that deficiency energy is an obvious pathology of GML. 
And the reversion by moxibustion acupoints treatment 
after 1  day, only citrate, α-KG and lactate reversed by 
moxibustion non-acupoints, also indicates again that 
moxibustion acupoints treatment can improve energy 
metabolism in GML rats (Fig. 6).
Glutathione is vital coenzymes with the crucial thiol 
group that make it have an effective antioxidant and can 
be synthesized from cysteine [40]. Glycine and serine 
(See figure on next page.)
Fig. 5 Disturbed metabolic pathways in stomach related to GML pathology and moxibustion treatment at three time points. 1, Phenylalanine, 
tyrosine and tryptophan biosynthesis; 2, d‑glutamine and d‑glutamate metabolism; 3, valine, leucine and isoleucine biosynthesis; 4, alanine, 
aspartate and glutamate metabolism; 5, phenylalanine metabolism; 6, glyoxylate and dicarboxylate metabolism; 7, citrate cycle (TCA cycle); 8, 
pyruvate metabolism; 9, starch and sucrose metabolism; 10, Aminoacyl‑tRNA biosynthesis; 11, glycolysis or gluconeogenesis; 12, arginine and 
proline metabolism; 13, tyrosine metabolism. Metabolites in bold were remarked metabolites associated with moxibustion treatment on GML 
rats. (Those in red (or blue) indicate concentration increases (or decreases) in comparison with the control group, while ones in black present no 
insignificant change)
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are important metabolic intermediates in glutathione 
metabolism. Taurine is synthesized from cysteine and 
has a vital role in antioxidation, neuroprotective, mem-
brane stabilization and osmoregulation [41–43]. Thus, 
serine and glycine can be used to enhance anti-oxidative 
reactions, improve immunity and prevent tissue injury 
[44, 45]. Methionine is known as a donator of the sulfur 
atom to form cysteine. So lower levels of serine, glycine, 
glutathione and methionine in medulla extracts as well as 
taurine in cortex extracts of GML rats and the depletion 
is reversed by moxibustion acupoints for 1 day and keep a 
increasing during the development process of lesions for 
4 days or 7 days (Fig. 6), suggesting that GML modeling 
may bring an weaken antioxidant ability and moxibustion 
treatment has good effect in improving them.
Besides, glycerophosphocholine (GPC) is formed in the 
breakdown of phosphatidylcholine (PC), a major compo-
nent of lecithin contributing to cellular proliferation and 
apoptosis [46, 47]. Increased GPC in cortex of GML rats 
may associate to a damaged in cell membrane [22], while 
its self-recovery and even reversion to low levels after 
7  days indicates an increased acquirement in synthesis 
of cell membranes to repair the previous damage (Fig. 6). 
But the levels of GPC were reversed by moxibustion acu-
points treatment for 1  day suggesting that moxibustion 
acupoints treatment has an effective on accelerating the 
cellular active.
In addition, glutamine is a precursor for GABA and it 
is supposed to be linked with positive intestinal effects, 
including maintenance of gut barrier function, aiding 
intestinal cell proliferation and differentiation and ant 
oxidative stress [48, 49]. Phenylalanine is known as a pre-
cursor for neurotransmitters catecholamines including 
tyramine, dopamine, epinephrine and norepinephrine 
[50]. The down-regulation in levels of glutamate, glu-
tamine and phenylalanine in brains of GML rats suggests 
a disturbance in neuronal signaling pathways caused by 
GML. While the reversion by moxibustion treatment 
gives an indication that moxibustion treatment has a 
good effect on GML by improving neurotransmitters 
function (Fig. 6).
Conclusions
Together, these findings suggests GML modeling brought 
disorders in energy metabolism, antioxidant ability, cel-
lular active and function of neurotransmitters in stomach 
and brain of rats. Although GML rats had some self-
restoration abilities, the moxibustion treatment showed 
an obvious improvement effects on GML especially in 
regulating energy metabolism and cellular active. In addi-
tion, moxibustion treatment also has a beneficial effect 
on GML by regulating antioxidant ability and function 
of neurotransmitters. The current study will be beneficial 
for better understanding the time-relative therapeutic 
mechanism of moxibustion on GML.
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